Dr. Capriotti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
919 Conestoga Rd
Building Two, Suite 106
Bryn Mawr, PA 19010Phone+1 610-525-5028
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Dermatology, 2006 - 2009
- Albert Einstein Medical CenterInternship, Transitional Year, 2005 - 2006
- Drexel University College of MedicineClass of 2005
Certifications & Licensure
- PA State Medical License 2005 - 2024
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FASDS) American Society for Dermatologic Surgery
Clinical Trials
- ALC-919 For The Treatment Of Common Warts Start of enrollment: 2015 Apr 01
- A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum Start of enrollment: 2017 Feb 27
- A Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients Start of enrollment: 2017 Oct 24
- Join now to see all
Publications & Presentations
PubMed
- 25 citationsTopical iodophor preparations: Chemistry, microbiology, and clinical utilityKara Capriotti, Capriotti Joseph A
Dermatology Online Journal. 2012-11-15 - 34 citationsThe risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta‐analysisKara Capriotti, J.A. Capriotti, S. Lessin, Shenhong Wu, Shari Goldfarb
The British Journal of Dermatology. 2015-09-01 - 63 citationsDimethyl Sulfoxide: History, Chemistry, and Clinical Utility in DermatologyKara Capriotti, Capriotti Joseph A
The Journal of Clinical and Aesthetic Dermatology. 2012-09-01
Press Mentions
- Veloce BioPharma Announces Positive Phase 2b Study Results for VBP-926 for Chemotherapy-Associated ParonychiaOctober 3rd, 2018
- New Gel Effective in Treating Molluscum ContagiosumMarch 5th, 2017
Professional Memberships
- Fellow
- Fellow
External Links
- Veloce BioPharmahttp://velocebiopharma.com
- Halodinehttp://halodine.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: